STOCK TITAN

Director Adler Oz details RSU and warrant holdings in Nexera (NEXR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3/A

Rhea-AI Filing Summary

Nexera Technologies Ltd director Adler Oz filed an amended statement of beneficial ownership that lists his existing equity awards rather than new trades. As of March 18, 2026, he holds 2 ordinary shares and a mix of restricted share units that vest over time.

The filing notes 1,448 RSUs granted on September 16, 2025, which vest in equal quarterly installments of 12.5% beginning December 10, 2025; 362 of these RSUs had vested and 1,086 remained unvested as of that date. It also discloses 8,100 additional RSUs granted on January 1, 2026, vesting quarterly at 12.5% starting January 1, 2026, all unvested as of March 18, 2026, plus ordinary warrants exercisable for 2 ordinary shares at a fixed price through August 30, 2027.

Positive

  • None.

Negative

  • None.
Insider Adler Oz
Role null
Type Security Shares Price Value
holding Ordinary warrants -- -- --
holding Warrants to purchase ordinary shares -- -- --
Holdings After Transaction: Ordinary warrants — 2 shares (Direct, null); Warrants to purchase ordinary shares — 1,450 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Ordinary shares held 2 shares Direct holdings as described in footnote as of March 18, 2026
First RSU grant 1,448 RSUs Granted September 16, 2025, vesting quarterly at 12.5% from December 10, 2025
Vested RSUs from first grant 362 RSUs Portion vested under 1,448-unit grant as of March 18, 2026
Unvested RSUs from first grant 1,086 RSUs Remaining under 1,448-unit grant as of March 18, 2026
Second RSU grant 8,100 RSUs Granted January 1, 2026, vesting quarterly at 12.5% from January 1, 2026
Unvested RSUs second grant 8,100 RSUs All remained unvested as of March 18, 2026
Ordinary warrants exercise price 43,749.20 per share Exercise price for warrants into 2 ordinary shares, expiring August 30, 2027
Underlying shares from warrants 2 shares Ordinary shares underlying ordinary warrants held directly
restricted share units ("RSUs") financial
"Represents (i) 2 ordinary shares, (ii) 1,448 restricted share units ("RSUs") Granted on September 16, 2025"
vesting commencement date financial
"RSUs Granted on September 16, 2025 and the vesting commencement date is September 10, 2025"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
ordinary warrants financial
""Ordinary warrants" with underlying security title "Ordinary shares" and an expiration date"
beneficial ownership financial
"filed an amended statement of beneficial ownership that lists his existing equity awards"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Adler Oz

(Last)(First)(Middle)
7 MEZADA STREET

(Street)
BNEI BRAK5126112

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Nexera Technologies Ltd [ NEXR ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrants to purchase ordinary shares1,450(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Ordinary warrants08/30/202208/30/2027Ordinary shares2$43,749.2D
Explanation of Responses:
1. Represents (i) 2 ordinary shares, (ii) 1,448 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 362 RSUs have vested and 1,086 remain unvested as of March 18, 2026; and (ii) 8,100 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026.
/s/ Oz Adler05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Nexera Technologies (NEXR) director Adler Oz report in this Form 3/A?

Adler Oz reports existing holdings in Nexera Technologies, including 2 ordinary shares, multiple restricted share unit grants, and ordinary warrants. The filing updates his beneficial ownership position rather than recording new share purchases or sales.

How many restricted share units does Adler Oz hold in Nexera Technologies (NEXR)?

Adler Oz holds 1,448 RSUs granted on September 16, 2025 and 8,100 RSUs granted on January 1, 2026. The first grant is partially vested, while the second grant remained fully unvested as of March 18, 2026.

What is the vesting schedule for Adler Oz’s 1,448 RSUs in NEXR?

The 1,448 RSUs granted on September 16, 2025 vest in equal quarterly installments of 12.5% beginning on December 10, 2025. By March 18, 2026, 362 RSUs had vested and 1,086 remained unvested under this grant.

What are the details of Adler Oz’s 8,100 RSUs in Nexera Technologies (NEXR)?

The 8,100 RSUs were granted on January 1, 2026 and vest in equal quarterly installments of 12.5% starting on January 1, 2026. All 8,100 RSUs remained unvested as of March 18, 2026, according to the filing footnote.

What ordinary warrant position does Adler Oz report in Nexera Technologies (NEXR)?

Adler Oz reports ordinary warrants exercisable into 2 ordinary shares of Nexera Technologies at an exercise price of 43,749.20 per share, with an expiration date of August 30, 2027. These warrants are held directly under his name.